Imbokodo study on HIV Fails efficacy trial
HIV activists have raised concern about the continued high rates of HIV infection in Africa and renewed calls for strengthening prevention strategies. This follows another HIV vaccine trial that failed to make it through clinical trials – the Imbokodo study started in 2017 by big pharma Johnson and Johnson. Ntando Yola, an HIV advocate with the…